학술논문

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial
Document Type
Article
Source
In: Blood. (Blood, 25 November 2021, 138(21):2042-2050)
Subject
Language
English
ISSN
15280020
00064971